Bay Harbor Wealth Management’s GSK GSK Stock Holding History

Bay Harbor Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,471	Closed	-$114K	–	437
2020 Q3	$116K	Sell	2,471 -1,759	-42%	-$88.1K	0.06%	108
2020 Q2	$216K	Sell	4,230 -1,056	-20%	-$54.2K	0.12%	86
2020 Q1	$250K	Sell	5,286 -946	-15%	-$50.5K	0.15%	76
2019 Q4	$366K	Buy	6,232 +21	+0.3%	+$1.17K	0.2%	67
2019 Q3	$328K	Sell	6,211 -157	-2%	-$8.08K	0.2%	66
2019 Q2	$319K	Sell	6,368 -286	-4%	-$14.4K	0.2%	76
2019 Q1	$348K	Sell	6,654 -310	-4%	-$15.5K	0.24%	67
2018 Q4	$333K	Buy	+6,964	New	+$343K	0.27%	66

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bay Harbor Wealth Management's GSK Position: Q4 2020 in Review

Bay Harbor Wealth Management sold out of GSK (GSK) in Q4 2020, closing a stake of 2,471 shares — an estimated $114K sold.

Bay Harbor Wealth Management first reported a position in GSK in Q4 2018 and held it in 8 quarters. The position peaked at $366K in Q4 2019. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Bay Harbor Wealth Management reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Bay Harbor Wealth Management sold 2,471 GSK shares in Q4 2020, an estimated $114K.
Bay Harbor Wealth Management first reported a position in GSK in Q4 2018 and held it in 8 quarters.
Bay Harbor Wealth Management's GSK position peaked at $366K in Q4 2019.
818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Bay Harbor Wealth Management's 13F filing for Q4 2020, filed 9 Feb 2021.